한글목차

항독소 세계 시장은 2025년에 13억 8,200만 달러, 2032년에는 24억 9,570만 달러에 달할 것으로 예상되며 2025년부터 2032년까지 연평균 8.8%의 성장률을 보일 것으로 예상됩니다.

그림. 2025년 항독소 시장 지역별 점유율(%)

세계 항독소 시장의 성장은 전 세계 열대 및 아열대 지역의 뱀과 전갈에 의한 물림과 전갈에 의한 쏘임 발생률 증가에 의해 주도되고 있습니다. 매년 500만 명 이상이 뱀에 물리고 그 중 약 270만 건이 중독되어 약 10만 명이 사망하고 있습니다. 효과적인 구충제가 출시되면서 많은 국가에서 뱀에 물린 피해자의 생존율과 회복률이 향상되어 구충제에 대한 수요가 증가하고 있습니다. 주요 제조업체들은 최신 면역학적 및 생화학적 방법을 이용한 생산 기술 개혁을 통해 새로운 항베놈을 개발하기 위해 노력하고 있습니다. 적시 치료와 항베놈의 가용성에 대한 인식 제고를 위한 투자 증가도 시장 성장을 가속할 수 있습니다.

시장 역학

세계 항독소 시장의 성장은 주로 전 세계 뱀과 전갈에 물린 발생률 증가에 의해 주도되고 있습니다. 세계보건기구(WHO)에 따르면 매년 약 540만 명이 뱀에 물리고 약 270만 명이 쏘여 약 13만 7000명이 사망합니다. 시장 관계자와 정부는 농촌 지역 주민들을 교육하고, 의료 시설에 대한 접근성을 개선하고, 외딴 지역에서 항독소의 가용성을 보장하기 위해 투자를 늘리고 있습니다. 그러나 항베놈은 높은 비용과 짧은 저장 기간, 보관 및 운송에 대한 제약과 관리로 인해 보급에 한계가 있습니다. 인식 부족, 전통적 믿음, 지리적 장벽으로 인해 개발도상국 피해자들이 적시에 치료를 받을 수 있는 기회를 제한하고 있습니다. 혁신적이고 효과적이며 합리적인 가격의 항베놈제를 연구하고 생산하는 시장 참여자들은 시장 성장의 기회를 제공할 수 있습니다.

본 조사의 주요 특징

• 세계의 항독소 시장을 상세하게 분석하고, 2022년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 항독소 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 항독소 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 항독소 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 항독소 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 항독소 시장, 항독소 유형별, 2020년-2032년

• 다가
• 단가

제6장 세계의 항독소 시장, 제품 유형별, 2020년-2032년

• 뱀 항독소
• 전갈 항독소
• 거미 항독소
• 기타

제7장 세계의 항독소 시장, 최종사용자별, 2020년-2032년

• 병원 및 클리닉
• 외래수술센터(ASC)
• 연구기관
• 기타

제8장 세계의 항독소 시장, 지역별, 2020년-2032년

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Pfizer, Inc.
  • Merck &Co., Inc.
  • Sanofi Pasteur
  • 4CSL Limited
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Instituto Bioclon SA de CV
  • Rare Disease Therapeutics, Inc.
  • Vins Bioproducts Limited
  • Bharat Serums and Vaccines Limited
  • Serum Institute of India Pvt. Ltd.
  • Incepta Pharmaceuticals Ltd.
  • MicroPharm Limited
  • Laboratorios Silanes SA
  • BTG plc
  • Vacsera
  • Indian Immunologicals Limited
  • AfrIPI(African Institute of Biomedical Science and Technology)

제10장 애널리스트 추천 사항

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Anti Venom Market is estimated to be valued at USD 1,382.0 Mn in 2025 and is expected to reach USD 2,495.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Anti Venom Market Share (%), By Region 2025

Global anti venom market growth is driven by rising incidence of snake bites and scorpion stings across tropical and sub-tropical regions of the world. Each year over 5 million people are bitten by snakes, out of which, around 2.7 million cases result in envenoming and around 100,000 deaths. There has been rising demand for anti-venom as the availability of effective anti-venoms has improved survival and recovery rates for victims of snake bites in many countries. Leading manufacturers are engaging in development of novel anti-venoms through reforms in production techniques using modern immunological and biochemical methods. Rising investments towards building awareness about timely treatment and availability of anti-venoms can also drive the market growth.

Market Dynamics:

Global anti venom market growth is primarily driven by increasing incidence of snake bites and scorpion stings globally. According to the World Health Organization, around 5.4 million people suffer from snake bites each year and about 2.7 million are envenomed with around 137,000 deaths. Rising investments by market players and governments towards educating rural populations, improving access to healthcare facilities and ensuring availability of anti-venoms across remote areas can offer lucrative opportunities. However, high costs of anti-venoms, short shelf-life requiring constrained and controlled storage and transportation can limit its widespread adoption. Lack of awareness, traditional beliefs and geographical barriers restrict timely treatment seeking for victims in developing nations. Market players involved in research and production of innovative, more effective and affordable anti-venoms can offer market growth opportunities.

Key features of the study:

• This report provides in-depth analysis of the global anti venom market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global anti venom market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bharat Serums & Vaccines, Haffkine Bio-Pharmaceutical Corporation, Vins Bioproducts, Bharat Biotech, and Serum Institute of India
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global anti venom market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti venom market

Detailed Segmentation-

• By Anti-venom Type
  • Polyvalent
  • Monovalent
• By Product Type
  • Snake Antivenom
  • Scorpion Anti-venom
  • Spider Anti-venom
  • Others
• By End User
  • Hospitals & clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • 4CSL Limited
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Instituto Bioclon S.A. de C.V.
  • Rare Disease Therapeutics, Inc.
  • Vins Bioproducts Limited
  • Bharat Serums and Vaccines Limited
  • Serum Institute of India Pvt. Ltd.
  • Incepta Pharmaceuticals Ltd.
  • MicroPharm Limited
  • Laboratorios Silanes S.A.
  • BTG plc
  • Vacsera
  • Indian Immunologicals Limited
  • AfrIPI (African Institute of Biomedical Science and Technology)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Anti-venom Type
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Anti Venom Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Anti Venom Market, By Anti-venom Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Polyvalent
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Monovalent
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Anti Venom Market, By Product Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Snake Antivenom
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Scorpion Anti-venom
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Spider Anti-venom
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Anti Venom Market, By End User, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Anti Venom Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Pfizer, Inc.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi Pasteur
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • 4CSL Limited
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Instituto Bioclon S.A. de C.V.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Rare Disease Therapeutics, Inc.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vins Bioproducts Limited
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bharat Serums and Vaccines Limited
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
  • Incepta Pharmaceuticals Ltd.
  • MicroPharm Limited
  • Laboratorios Silanes S.A.
  • BTG plc
  • Vacsera
  • Indian Immunologicals Limited
  • AfrIPI (African Institute of Biomedical Science and Technology)

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact